F

Fred Hutchinson Cancer Center

Nonprofit cancer treatment, research, and trials

IT Contracts & Licensing Specialist 3

Full-TimeDeadline 8/13/27
$97.8k - $146.7k/yr
Senior
Bachelor's
Seattle, WA, USA
HybridSome on-campus work is required; flexibility may be available for certain positions.
Contract Management
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in business or a related field, although additional experience may substitute for the educational requirement.
  • At least 5 years of procurement experience, including demonstrated experience in the IT software sourcing category.
  • Experience with software licensing and software-as-a-service contract models.
  • Understanding of contract terms and the ability to identify problematic clauses.
  • Analytical skills for cost comparison and trend analysis.
  • Experience independently negotiating software, software-as-a-service, and services contracts, including price and commercial terms.
  • Demonstrated experience reading complex software, software-as-a-service, and services contracts, identifying commercial and risk issues, and recommending negotiation strategy.
  • Demonstrated ability to manage routine renewals and contract reviews independently, owning decisions end to end.
  • Knowledge of procurement best practices and cost optimization techniques.
Responsibilities
  • Conduct contract reviews and analysis for renewals, identifying cost drivers, price escalations, and optimization opportunities.
  • Analyze software licensing agreements, including usage rights, termination clauses, and vendor lock-in provisions.
  • Track contract terms and renewal dates to ensure proactive management.
  • Identify consolidation opportunities across vendor relationships and contracts.
  • Manage the IT contract renewal pipeline end to end, including notifying business owners of upcoming renewals, maintaining data accuracy, and triggering the review process.
  • Maintain proactive visibility across the full IT contract portfolio so renewals are managed ahead of expiration.
  • Lead vendor negotiations and renewals, applying market pricing, competitive alternatives, and benchmarking data to drive savings and improved commercial terms.
  • Manage vendor communications during contract negotiations and renewals.
  • Own routine contract renewals and reviews end to end, exercising independent judgment on commercial terms and escalating when risk, scope change, or contract value exceeds a defined threshold.
  • Perform spend analysis to identify trends, anomalies, and savings opportunities.
  • Research alternative solutions and competitive pricing for existing contracts.
  • Support license optimization by analyzing usage data against contracted amounts.
  • Assist with request for proposal development and vendor evaluation processes.
  • Maintain procurement databases and contract repositories.
  • Generate reports on procurement metrics, savings, and vendor performance.
  • Support compliance with organizational procurement policies and procedures.
Desired Qualifications
  • Procurement experience specifically in the IT software sourcing category.
  • Ability to lead without authority and build engagement in a process environment that is still maturing.
  • Strong written and verbal communication, with the ability to tailor stakeholder communication across technical and nontechnical audiences.
  • Experience partnering directly with IT directors and business owners to influence procurement decisions.
  • Familiarity with artificial intelligence tools and their application to procurement and software contracts; artificial intelligence-related certifications are a plus.

About the company

F

Fred Hutchinson Cancer Center

View

Fred Hutchinson Cancer Center is a nonprofit cancer treatment and research institute serving the Pacific Northwest and beyond. It provides a full range of cancer care, including treatments that may not be available elsewhere, and offers patients the chance to participate in clinical trials. The center accomplishes its work through a combination of patient care, research grants, and fundraising, and collaborates with UW Medicine and other regional providers to extend its reach. Internationally, it operates facilities in Uganda and South Africa to advance research and collaboration. The organization’s revenue comes from patient services, grants, and fundraising events. Its central goal is to eliminate cancer and related diseases by improving treatments and ultimately finding a cure.

Company Size

1,001-5,000

Company Stage

Grant

Total Funding

$300K

Headquarters

Seattle, Washington

Founded

1975

Get referred to Fred Hutchinson Cancer Center

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fred Hutch won a 2026 PCORI award for a $15 million AML trial initiative.
  • July 2026 Evergreen Fund awarded $975,000 to eight projects with industry potential.
  • September 2026 HRDefine and prostate-cancer advances strengthen Fred Hutch's clinical and translational pipeline.

What critics are saying

  • The NLRB APP election in September 2026 exposes frontline workforce dissatisfaction and organizing momentum.
  • Fred Hutch depends on NIH, PCORI, and philanthropy; grant slippage quickly constrains programs.
  • Cancer AI Alliance rivals include Dana-Farber, MSK, Johns Hopkins, AWS, Google Cloud, and Ai2.

What makes Fred Hutchinson Cancer Center unique

  • Fred Hutch leads Cancer AI Alliance with Dana-Farber, MSK, and Johns Hopkins, since 2024.
  • The 2026 AI BioDesign accelerator with UW and Allen Institute builds open biology models.
  • Fred Hutch combines cancer care, translational research, and patient trials across Seattle-area facilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Health Savings Account/Flexible Spending Account
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Paid Parental Leave
  • Sabbatical Leave
  • Tuition Reimbursement

Company News

Associated Press
Sep 3rd, 2026
Allen Institute, UW, and Fred Hutch launch AI BioDesign accelerator to decode biology's design rules

The Allen Institute, University of Washington, and Fred Hutch Cancer Center have launched AI BioDesign, a collaborative accelerator combining artificial intelligence with experimental biology to explore biological design space. The initiative aims to generate open models, datasets, and tools for creating biological solutions in healthcare, environmental challenges, and advanced technologies. AI BioDesign will operate through a continuous learning platform where AI models propose biological designs, scientists test them at scale, and results feed back into the models. The accelerator focuses on building modular models from tractable biological problems and conducting multiplex experiments. All models, datasets, assays, and benchmarks will be openly shared. The collaboration leverages Seattle's scientific ecosystem, combining the Allen Institute's open-science platforms, UW's synthetic biology expertise, and Fred Hutch's cellular systems knowledge. The project is supported by Fund for Science and Technology, a foundation in the Paul G. Allen philanthropic ecosystem.

Ensoma
Jul 16th, 2026
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines

Company’s Engenious™ Vectors Delivered without Stem Cell Collection or Myeloablative Conditioning in Outpatient and Low-resource Settings, Enabling Access Worldwide

GeekWire
Apr 17th, 2025
Tech Moves: Smartsheet Names Chief Product Officer; Meta Vet Joins Tech Alliance; And More

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Arora. (Smartsheet Photo)— Pratima Arora has been named chief product officer at Smartsheet, a new senior executive role at the Bellevue, Wash.-based enterprise software giant.A longtime product and technology leader, Arora will be responsible for Smartsheet’s product management, product marketing, user experience, pricing and packaging, and digital and product partnerships.She previously held senior leadership roles at Atlassian and Salesforce, and was most recently the chief product and technology officer at Chainalysis.“After a fantastic 4-month break to recharge, spend quality time with family, and dive deep into the world of GenAI, I’m energized and ready for what’s next,” Arora said on LinkedIn. “There’s no better place than Smartsheet to begin this new chapter. With a strong foundation, a passionate customer base, and a unique opportunity to reimagine collaborative work through AI, the road ahead is full of possibility.”Smartsheet also announced that Nick Dunn, an eight-year veteran of the company, is now general counsel, responsible for leading the company’s legal, privacy, and risk functions, including corporate governance initiatives.Launched in 2005, Smartsheet makes cloud-based enterprise work management technologies for managing and tracking projects, collaborating, storing data, and automating and assigning tasks, among other capabilities. It serves 85% of the Fortune 500 as customers

PR Newswire
Apr 4th, 2025
Google Cloud And Ai2 Commit $20M To Advance Ai-Powered Research For The Cancer Ai Alliance

Google Cloud to provide advanced and secure technology, while Ai2 to lead AI training and development for AI cancer modelsSEATTLE and SUNNYVALE, Calif., April 4, 2025 /PRNewswire/ -- Today, Google Cloud and Ai2 announced they have partnered with the Cancer AI Alliance (CAIA), a pioneering consortium uniting leading cancer research institutions and technology companies to harness artificial intelligence (AI) in the fight against cancer. Google Cloud and Ai2 are each giving $10 million to the initiative and providing access to technology solutions that will help speed scientific discovery. Google Cloud will power planet-scale AI infrastructure and data analytics tools, while Ai2 will provide critical expertise in training large-scale models focusing on cancer research

GeekWire
Apr 4th, 2025
Ai2 And Google Cloud Join Cancer Ai Alliance With A Total Of $20M In Commitments

Inside the Allen Institute for AI in Seattle. (GeekWire File Photo / Todd Bishop)The Allen Institute for AI (Ai2) is joining a high-profile national effort to accelerate cancer research using artificial intelligence, committing $10 million in researcher time and technical expertise to the Cancer AI Alliance, a consortium led by the Fred Hutch Cancer Center.Google Cloud is also committing $10 million in resources to the effort, planning to provide computing infrastructure and tools to help process large volumes of cancer data. They say the goal is to create a novel AI infrastructure that supports the training and deployment of AI models across institutions while maintaining data security and privacy standards for patients.The Cancer AI Alliance was announced in October 2024 as a joint effort among four major cancer centers: Fred Hutch, Dana-Farber, Memorial Sloan Kettering, and Johns Hopkins. Backed by more than $40 million in initial support from AWS, Microsoft, NVIDIA, Deloitte, and Slalom, the project aims to use artificial intelligence to analyze large volumes of cancer data across institutions. Seattle-based Fred Hutch is serving as the lead coordinating center.Ai2 CEO Ali Farhadi in his Seattle office. (GeekWire File Photo / Todd Bishop)In a previous interview with GeekWire, Ai2 CEO Ali Farhadi said the Cancer AI Alliance represents the kind of real-world challenge that needs customized, domain-specific AI models. The Seattle-based AI institute focuses on open-source artificial intelligence technologies.Farhadi said Ai2’s role in the Cancer AI Alliance reflects Ai2’s goal to apply cutting-edge research where it can have the most tangible impact on the world.“Any step in the right direction in that space is going to be a risk worth taking, and that’s the kind of impact that we’re after,” Farhadi said, explaining Ai2’s ambitions for 2025 on the GeekWire Podcast. “If you’re actually trying to solve a real problem, there is no turnkey solution.”The Cancer AI Alliance has said it expects initial research results by the end of 2025